
Segmed is a leading Real-World Imaging Data (RWiD) company founded by Stanford engineers and physicians, providing a technology-enabled platform for high-quality, structured, de-identified medical imaging data and multimodal datasets from a diverse population. The platform supports AI and real-world data research in diagnostics and therapeutics, enabling pharmaceutical, medical device, and technology industries to access millions of diagnostic-grade medical images globally. Segmed's data powers research for external control arms, imaging biomarker identification, algorithm development, and validation, with a network of over 2,000 healthcare partner sites and more than 100 million imaging studies sourced from 50 US states and 5 continents. The company offers subscription-based access to regulatory-grade validation datasets and supports FDA/CE regulatory processes, positioning itself as a premier authority in medical imaging data for healthcare innovation.

Segmed is a leading Real-World Imaging Data (RWiD) company founded by Stanford engineers and physicians, providing a technology-enabled platform for high-quality, structured, de-identified medical imaging data and multimodal datasets from a diverse population. The platform supports AI and real-world data research in diagnostics and therapeutics, enabling pharmaceutical, medical device, and technology industries to access millions of diagnostic-grade medical images globally. Segmed's data powers research for external control arms, imaging biomarker identification, algorithm development, and validation, with a network of over 2,000 healthcare partner sites and more than 100 million imaging studies sourced from 50 US states and 5 continents. The company offers subscription-based access to regulatory-grade validation datasets and supports FDA/CE regulatory processes, positioning itself as a premier authority in medical imaging data for healthcare innovation.
Product: De-identified, regulatory-grade medical imaging and linked clinical data platform (Openda)
Scale: Catalog of ~100–150M imaging studies and 2,000+ healthcare partner sites
Founding: Founded by Stanford engineers and physicians
Recent funding: Series A $10.4M (Sep 3, 2024); total disclosed funding $20,420,000
Access to high-quality, standardized medical imaging and linked clinical data for AI and clinical research.
Health data / Medical imaging / Life sciences
2000000+
Seed round reported December 2020; Crunchbase reporting noted total disclosed funding of $2.75M at that time.
10400000.00
Series A announced as $10.4M with participation from multiple clinical and venture investors and existing backers.
“Led Series A by iGan Partners and Advocate Health; participation includes clinical and strategic investors and existing venture backers”